| 1/3 | US=11 / Transplante Torlakovic EE, Naresh KN, Brunning RD. Cluster of differentiation markers. In: ___. Bone marrow immunohistochemistry. Chicago: American Society for Clinical Nutrition, 2009. p. 13-152. ISBN 978-0891895725. TRANSPLANTE; IMUNISTOQUIMICA; MEDULA OSSEA; MARCADORES; GRUPO DE DIFERENCIACAO; CD1A; CD2; CD3; CD4; CD5; CD7; CD8; CD9; CD10; CD14; CD15; CD16; CD20; CD21; CD22; CD23; CD25; CD30; CD31; CD33; CD34; CD35; CD45; CD56; CD57; CD61; CD42B; CD68; CD79A; CD99; CD117; CD123; CD138; CD235A; GLYCOPHORIN A |
| 2/3 | US=84-A / Biol/Mol Becker C, Neurath MF. Transformig growth factor-B in developing and advanced cancers: TGF-B dependent T-Cell regulation in colitis and colon cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 153-66. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; CD25; COLITE; CANCRO DO COLON; TREG; FOXP3; CELULA T; REGULACAO |
| 3/3 | US=970 / Dissertação/FAP Carvalho MLR. Impacto do Complexo Repressor Polycomb 2 (PRC2) na modulação in vitro de células T CD8+ humanas. [Impact of Polycomb Repressive Complex 2 (PRC2) on the in vitro modulation of human CD8+ T cells]. São Paulo, 2023. 62 p. Dissertação(Mestrado)-Fundação Antonio Prudente. Disponível em: https://accamargo.phlnet.com.br/MESTRADO/2023/MLRCarvalho/MLRCarvalho.pdf LINFOCITOS T; MODULACAO EPIGENETICA; CELULAS CAR-T; RESPOSTA ANTITUMORAL |